Peginterferon Alfa-2a for AIDS-Associated Kaposi Sarcoma: Experience With 10 PatientsROKX, Casper; VAN DER ENDE, Marchina E; VERBON, Annelies et al.Clinical infectious diseases. 2013, Vol 57, Num 10, pp 1497-1499, issn 1058-4838, 3 p.Article

Sexually transmitted reinfection with a new hepatitis C genotype during pegylated interferon and ribavirin therapyDEN HOLLANDER, Jan G; RIJNDERS, Bart J; VAN DOORNUM, Gerard J. J et al.AIDS (London). 2005, Vol 19, Num 6, pp 639-640, issn 0269-9370, 2 p.Article

CCR5-Restricted HIV Type 2 Variants from Long-Term Aviremic Individuals Are Less Sensitive to Inhibition by β-Chemokines Than Low Pathogenic HIV Type 1 VariantsBLAAK, Hetty; BOERS, Patrick H. M; VAN DER ENDE, Marchina E et al.AIDS research and human retroviruses. 2008, Vol 24, Num 3, pp 473-484, issn 0889-2229, 12 p.Article

A Prospective Open Study of the Efficacy of High-Dose Recombinant Hepatitis B Rechallenge Vaccination in HIV-Infected PatientsDE VRIES-SLUIJS, Theodora E. M. S; HANSEN, Bettina E; VAN DOORNUM, Gerard J. J et al.The Journal of infectious diseases. 2008, Vol 197, Num 2, pp 292-294, issn 0022-1899, 3 p.Article

Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patientsVAN DER ENDE, Marchina E; PRINS, Jan M; BRINKMAN, Kees et al.AIDS (London). 2003, Vol 17, pp S55-S61, issn 0269-9370, SUP3Article

Once-daily indinavir plus ritonavir : preliminary results of the PIPO studyBURGER, David M; HUGEN, Patricia W. H; VAN DER ENDE, Marchina E et al.AIDS (London). 2000, Vol 14, Num 16, pp 2621-2623, issn 0269-9370Article

Determination of the antiretroviral drug tenofovir in plasma from HIV-infected adults by ultrafast isotope dilution MALDI-triple quadrupole tandem mass spectrometryMEESTERS, Roland J. W; VAN KAMPEN, Jeroen J. A; SCHEUER, Rachel D et al.Journal of mass spectrometry. 2011, Vol 46, Num 3, pp 282-289, issn 1076-5174, 8 p.Article

Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz DiscontinuationsVAN LUIN, Matthijs; GRAS, Luuk; RICHTER, Clemens et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 2, pp 240-245, issn 1525-4135, 6 p.Conference Paper

Nelfinavir and nevirapine side effects during pregnancyTIMMERMANS, Sarah; TEMPELMAN, Claire; GODFRIED, Mieke H et al.AIDS (London). 2005, Vol 19, Num 8, pp 795-799, issn 0269-9370, 5 p.Article

Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavirVAN LUIN, Matthijs; VAN DER ENDE, Marchina E; KUKS, Paul F. M et al.AIDS (London). 2010, Vol 24, Num 8, pp 1223-1226, issn 0269-9370, 4 p.Article

Safety of long-term interruption of successful antiretroviral therapy : the ATHENA cohort studyWIT, Ferdinand W. N. M; BLANCKENBERG, Daniel H; BRINKMAN, Kees et al.AIDS (London). 2005, Vol 19, Num 3, pp 345-348, issn 0269-9370, 4 p.Article

A Randomized Controlled Study of Accelerated Versus Standard Hepatitis B Vaccination in HIV-Positive PatientsDE VRIES-SLUIJS, Theodora E. M. S; HANSEN, Bettina E; VAN DER ENDE, Marchina E et al.The Journal of infectious diseases. 2011, Vol 203, Num 7, pp 984-991, issn 0022-1899, 8 p.Article

Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrationsBURGER, David M; HUGEN, Patricia W. H; AARNOUTSE, Rob E et al.Therapeutic drug monitoring. 2003, Vol 25, Num 1, pp 73-80, issn 0163-4356, 8 p.Article